Herbas VPB

Print
EN | LT
LT - 2-Amino-1-hidroksietil-8-hidroksichinolin-2(1H)-ono druskų dariniai, turintys tiek 2 adrenerginio receptoriaus agonisto, tiek M3 muskarininio receptoriaus antagonisto aktyvumus
EN - SALTS OF 2-AMINO-1-HYDROXYETHYL-8-HYDROXYQUINOLIN-2(1H)-ONE DERIVATIVES HAVING BOTH 2 ADRENERGIC RECEPTOR AGONIST AND M3 MUSCARINIC RECEPTOR ANTAGONIST ACTIVITIES

Legal status

Patent lapsed (non-payment of fees)

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/4709 (2006.01)
C07D 409/14 (2006.01)
A61P 11/00 (2006.01)
European patent
(11) Number of the document 2961407
(13) Kind of document T
(96) European patent application number 14706652.6
Date of filing the European patent application 2014-02-27
(97) Date of publication of the European application 2016-01-06
(45) Date of publication and mention of the grant of the patent 2018-04-11
(46) Date of publication of the claims translation 2018-05-10
PCT application
(86) Number PCT/EP2014/053871
Date 2014-02-27
PCT application publication
(87) Number WO 2014/131851
Date 2014-09-04
Priority applications
(30) Number Date Country code
13382060 2013-02-27 EP
201361804558 P 2013-03-22 US
Inventors
(72)
CARRERA CARRERA, Francesc, ES
PAJUELO LORENZO, Francesca, ES
PEREZ ANDRES, Juan Antonio, ES
PRAT QUIŃONES, Maria, ES
PUIG DURAN, Carlos, ES
JULIA JANE, Montserrat, ES
Grantee
(73) Almirall S.A., Ronda del General Mitre, 151, 08022 Barcelona, ES
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) 2-Amino-1-hidroksietil-8-hidroksichinolin-2(1H)-ono druskų dariniai, turintys tiek 2 adrenerginio receptoriaus agonisto, tiek M3 muskarininio receptoriaus antagonisto aktyvumus
  SALTS OF 2-AMINO-1-HYDROXYETHYL-8-HYDROXYQUINOLIN-2(1H)-ONE DERIVATIVES HAVING BOTH 2 ADRENERGIC RECEPTOR AGONIST AND M3 MUSCARINIC RECEPTOR ANTAGONIST ACTIVITIES
Last renewal fee
Payment date Validity (years) Amount
2022-02-01 9 208.00 EUR
Legal status
Patent lapsed (non-payment of fees)
Invalidation date 2023-02-27